Data / Form D filings / Redona Therapeutics, Inc.
Redona Therapeutics, Inc.: Form D filings
Redona Therapeutics, Inc., a biotechnology company in Watertown, MA, filed 4 Form D notices with the SEC between 2018 and 2023. The latest, on July 31, 2023, reports $60.8 million sold of a $76.9 million offering to 11 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 490 ARSENAL WAY, SUITE 100B, Watertown, MA, 02472
- Phone
- (617) 603-6060
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1751998
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 31, 2023 | Amendment | $76,942,575 | $60,825,939 | $16,116,636 | 11 | Aug 22, 2018 | sec.gov |
| Jul 31, 2023 | New notice | $11,907,796 | $5,953,898 | $5,953,898 | 8 | Jul 21, 2023 | sec.gov |
| Jun 16, 2022 | Amendment | $76,942,575 | $60,825,939 | $16,116,636 | 11 | Aug 22, 2018 | sec.gov |
| Sep 6, 2018 | New notice | $65,185,644 | $25,069,279 | $40,116,365 | 7 | Aug 22, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kazumi Shiosaki | Executive Officer, Director | |
| Henrijette Richter | Director | |
| Michal Silverberg | Director | |
| Christine Brennan | Director | |
| Luke Evnin | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Jul 31, 2023 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Redona Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.